Chondrogel is an intra-articular injectable formulation containing a bioactive collagen tri-peptide complex designed to support cartilage metabolism and joint tissue regeneration. Collagen tri-peptides are highly bioavailable fragments derived from collagen that act as biological signalling molecules within connective tissues. These peptides stimulate chondrocyte activity, promote extracellular matrix synthesis, and support the production of key structural components of cartilage, including type II collagen and proteoglycans.

Beyond structural support, collagen peptides influence signalling pathways involved in cartilage repair, tissue remodeling, and modulation of joint inflammation, helping to stabilise the intra-articular environment in degenerative joint disease. Supplied as a 2 ml sterile injectable solution, Chondrogel is intended as an adjunctive intra-articular therapy in the management of osteoarthritis, degenerative joint disease, cartilage injury, and inflammatory joint conditions. By supporting cartilage metabolism and extracellular matrix regeneration, Chondrogel provides a biomaterial-based therapeutic approach to improving joint function and slowing degenerative processes in musculoskeletal disease.

Active Substance(s) – Collagen Tripeptide, Sodium Hyaluronate

Strength – 20mg

Quantity – 2ml

Format – 2ml Applicator